Changeflow GovPing Pharma & Drug Safety Indolizine compounds patent for mental disorder...
Routine Notice Added

Indolizine compounds patent for mental disorders inflammation

Email

Summary

Indolizine compounds patent for mental disorders inflammation

Source document (simplified)

← EPO Patent Bulletin

INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR INFLAMMATION

Publication EP4499058A2 Kind: A2 Mar 18, 2026

Applicants

Tactogen Inc.

Inventors

BAGGOTT, Matthew, J.

IPC Classifications

A61K 31/137 20060101AFI20260211BHEP A61K 31/13 20060101ALI20260211BHEP A61K 31/395 20060101ALI20260211BHEP A61K 31/135 20060101ALI20260211BHEP A61K 31/4162 20060101ALI20260211BHEP A61K 31/33 20060101ALI20260211BHEP C07D 471/04 20060101ALI20260211BHEP A61P 25/00 20060101ALI20260211BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.